Bionano Genomics
BNGO
BNGO
148 hedge funds and large institutions have $187M invested in Bionano Genomics in 2022 Q1 according to their latest regulatory filings, with 21 funds opening new positions, 43 increasing their positions, 51 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
148
Holders Change
-1
Holders Change %
-0.67%
% of All Funds
2.34%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
21
Increased
43
Reduced
51
Closed
22
Calls
$5.32M
Puts
$3.54M
Net Calls
+$1.78M
Net Calls Change
-$4.02M
Top Buyers
| 1 |
1
Allianz Asset Management
Munich,
Germany
|
$3.19M |
| 2 |
2
Vanguard Group
Malvern,
Pennsylvania
|
$41M |
| 3 |
3
BNP Paribas Financial Markets
Paris,
France
|
$2.18M |
| 4 |
4
State Street
Boston,
Massachusetts
|
$19.9M |
| 5 |
5
Morgan Stanley
New York
|
$5.26M |
Top Sellers
| 1 |
1
Citadel Advisors
Miami,
Florida
|
$1.99M |
| 2 |
EGM
2
Engineers Gate Manager
New York
|
$0 |
| 3 |
3
Squarepoint
New York
|
$0 |
| 4 |
4
Millennium Management
New York
|
$620K |
| 5 |
5
Marshall Wace
London,
United Kingdom
|
$0 |
